199 related articles for article (PubMed ID: 36094141)
21. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda.
Baldeh AO; Millard C; Pollock AM; Brhlikova P
J Pharm Policy Pract; 2023 Jan; 16(1):18. PubMed ID: 36717871
[TBL] [Abstract][Full Text] [Related]
22. Affordability of Medication Therapy in Diabetic Patients: A Scenario-Based Assessment in Iran's Health System Context.
Zarei L; Peymani P; Moradi N; Kheirandish M; Mirjalili M; Zare M
Int J Health Policy Manag; 2022 Apr; 11(4):443-452. PubMed ID: 32861229
[TBL] [Abstract][Full Text] [Related]
23. Trends in access to anti-malarial treatment in the formal private sector in Uganda: an assessment of availability and affordability of first-line anti-malarials and diagnostics between 2007 and 2018.
Kibira D; Ssebagereka A; van den Ham HA; Opigo J; Katamba H; Seru M; Reed T; Leufkens HG; Mantel-Teeuwisse AK
Malar J; 2021 Mar; 20(1):142. PubMed ID: 33691704
[TBL] [Abstract][Full Text] [Related]
24. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
25. A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list.
Naicker I; Suleman F; Perumal-Pillay VA
J Pharm Policy Pract; 2022 Dec; 15(1):97. PubMed ID: 36482421
[TBL] [Abstract][Full Text] [Related]
26. Nationwide survey of the availability and affordability of asthma and COPD medicines in Nigeria.
Ozoh OB; Eze JN; Garba BI; Ojo OO; Okorie EM; Yiltok E; Okoli CV; Hammangabdo A; Beran D
Trop Med Int Health; 2021 Jan; 26(1):54-65. PubMed ID: 32985028
[TBL] [Abstract][Full Text] [Related]
27. Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
Moye-Holz D; Ewen M; Dreser A; Bautista-Arredondo S; Soria-Saucedo R; van Dijk JP; Reijneveld SA; Hogerzeil HV
BMC Health Serv Res; 2020 May; 20(1):424. PubMed ID: 32410676
[TBL] [Abstract][Full Text] [Related]
28. Implementation of medicines pricing policies in sub-Saharan Africa: systematic review.
Koduah A; Baatiema L; de Chavez AC; Danso-Appiah A; Kretchy IA; Agyepong IA; King N; Ensor T; Mirzoev T
Syst Rev; 2022 Dec; 11(1):257. PubMed ID: 36457058
[TBL] [Abstract][Full Text] [Related]
29. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
30. National medicines regulatory authorities financial sustainability in the East African Community.
Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
[TBL] [Abstract][Full Text] [Related]
31. Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries.
Vialle-Valentin CE; Serumaga B; Wagner AK; Ross-Degnan D
Health Policy Plan; 2015 Oct; 30(8):1044-52. PubMed ID: 25255920
[TBL] [Abstract][Full Text] [Related]
32. Progress Update: Palliative Care Development Between 2017 and 2020 in Five African Countries.
Luyirika E; Lohman D; Ali Z; Atieno M; Mahenge A; Mmbando P; Muinga E; Musyoki D; Mwesiga MD; Namisango E; Nosim P; Opio G; Pardy S; Ruzima A; Skowronska E; Uhagaze B; Zalwango J; Aluso A
J Pain Symptom Manage; 2022 May; 63(5):729-736. PubMed ID: 34973351
[TBL] [Abstract][Full Text] [Related]
33. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
Todesco B; Ostuzzi G; Barbui C
Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
[TBL] [Abstract][Full Text] [Related]
34. Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018.
Lyus R; Pollock A; Ocan M; Brhlikova P
Bull World Health Organ; 2020 Aug; 98(8):530-538. PubMed ID: 32773898
[TBL] [Abstract][Full Text] [Related]
35. Price, Availability, and Affordability of Antineoplastic Medicines in Harare's Public and Private Institutions: Implication for Access.
Mutyavaviri SN; Mensah KB; Marume A; Boamah Mensah AB; Bangalee V
Value Health Reg Issues; 2021 Sep; 25():118-125. PubMed ID: 33965656
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan.
Bibi M; Haq NU; Kareem A; Ullah H; Baloch N; Rehman G; Nasim A
Int J Public Health; 2022; 67():1604375. PubMed ID: 35872706
[No Abstract] [Full Text] [Related]
37. Availability of WHO Essential Medicines for Cancer Treatment in Botswana.
Martei YM; Chiyapo S; Grover S; Ramogola-Masire D; Dryden-Peterson S; Shulman LN; Tapela N
J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241225
[TBL] [Abstract][Full Text] [Related]
38. An evaluation of rational prescribing in hospital outpatient practice in Sierra Leone and assessment of affordability of a prescription as an outcome.
Cole CP; Routledge P
Pan Afr Med J; 2018; 31():174. PubMed ID: 31086626
[TBL] [Abstract][Full Text] [Related]
39. Appropriateness and affordability of prescriptions to diabetic patients attending a tertiary hospital in Eastern Uganda: A retrospective cross-sectional study.
Obakiro SB; Kiyimba K; Napyo A; Kanyike AM; Mayoka WJ; Nnassozi AG; Aguti B; Akech GM; Waako JP
PLoS One; 2021; 16(1):e0245036. PubMed ID: 33400703
[TBL] [Abstract][Full Text] [Related]
40. Access to essential medicines to treat chronic respiratory disease in low-income countries.
Bissell K; Perrin C; Beran D
Int J Tuberc Lung Dis; 2016 Jun; 20(6):717-28. PubMed ID: 27155173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
